SharonAI Holdings, Inc. Class A Common Stock
NASDAQ:SHAZInformation Technology Services
+$5.13 today
- Market cap
- $784.32M
- Beta
- 5.93
- P/E (TTM)
- -21.7
- EPS (TTM)
- -$4.16
Volume 3.48M
Average 0.56M
SHAZ Accumulated OCI
Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.
SharonAI Holdings, Inc. Class A Common StockNASDAQ: SHAZ
Accumulated OCI · Q2 FY2026 · quarter ended Jun 2026
Accumulated OCI turns negative
Q2 FY2026 Accumulated OCI was -$3.42M, compared with $76.08K a year earlier.
Context
- Accumulated OCI amounted to 0.1% of total assets at the end of Q2 FY2026, down 0.1 pp from a year earlier.
What to watch
Whether Accumulated OCI keeps falling in the next quarterly balance sheet after a -4592.4% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Accumulated OCI history
USD · from the balance sheet
- Latest · FY2025
- (372.99K) USD
- Year-over-year change
- -188.0%
| Period | Period end | Accumulated OCI | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (372.99K) | -188.0% |
| FY2024 | 2024-12-31 | 423.86K | — |
Accumulated OCI vs competitors
How SHAZ compares with its peers on the latest reported figures
- SHAZ's Jun 2026 Accumulated OCI of -$3.42M is the lowest of the 7 companies compared; the peer median is $0.
- Its year-over-year change of -4592.4% is the lowest of 5, against a peer median of +100.0%.
- Accumulated OCI amounts to 0.1% of total assets for SHAZ, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $75M | +5941.1% | — | 0.1% | |
| Jun 2026 | $0 | +100.0% | — | 0.0% | |
| Aug 2026 | $0 | — | — | 0.0% | |
KEELKeel Infrastructure Corp. | Jun 2026 | $0 | -100.0% | — | 0.0% |
| Mar 2026 | $0 | — | — | 0.0% | |
WYFIWhiteFiber, Inc. Ordinary Shares | Mar 2026 | -$651 | +100.0% | — | 0.0% |
SHAZSharonAI Holdings, Inc. Class A Common Stock | Jun 2026 | -$3.42M | -4592.4% | — | 0.1% |
QMLSQumulusAI, Inc. Common Stock | — | — | — | — | — |
CHRNEkso Bionics Holdings, Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding SHAZ) | $0 | +100.0% | — | 0.0% | |
Competitors are the stored peer set for SHAZ. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|
| Cash & Equivalents | 4.42M | 71.07M |
| Short-term Investments | 0 | 0 |
| Net Receivables | 984.55K | 15.92M |
| Inventory | 0 | 0 |
| Other Current Assets | 770.86K | 1.42M |
| Total Current Assets | 6.21M | 88.42M |
| Property, Plant & Equipment (Net) | 5.51M | 22.35M |
| Goodwill | 18.04M | 18.04M |
| Intangible Assets | 2.38M | 0 |
| Long-term Investments | 0 | 0 |
| Tax Assets | 0 | 0 |
| Other Non-current Assets | 0 | 4.33M |
| Total Non-current Assets | 25.94M | 44.72M |
| Total Assets | 32.15M | 133.14M |
| Account Payables | 404.85K | 3.43M |
| Short-term Debt | 5.44K | 131.27M |
| Tax Payables | 40.71K | 0 |
| Deferred Revenue | 0 | 0 |
| Other Current Liabilities | 50.16K | 3.59M |
| Total Current Liabilities | 1.15M | 139.37M |
| Long-term Debt | 0 | 0 |
| Deferred Tax Liabilities | 327.54K | 0 |
| Deferred Revenue (Non-current) | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 |
| Total Non-current Liabilities | 1.09M | 3.92M |
| Total Liabilities | 2.24M | 143.29M |
| Common Stock | 107 | 1.2K |
| Retained Earnings | (3.91M) | (43.53M) |
| Accumulated OCI | 423.86K | (372.99K) |
| Other Stockholders Equity | 0 | 0 |
| Minority Interest | 86.1K | (108.89K) |
| Total Equity | 29.91M | (10.15M) |
| Total Debt | 952.14K | 136.26M |
| Net Debt | (3.47M) | 65.19M |
SharonAI Holdings, Inc. Class A Common Stock
NASDAQ:SHAZ
Intrinsic Alpha fair value
Locked
Current Price
$21.99
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.